Pharmaids Pharmaceuticals Limited (BOM:524572)

India flag India · Delayed Price · Currency is INR
30.88
+0.63 (2.08%)
At close: Apr 28, 2026
-52.51%
Market Cap 1.04B
Revenue (ttm) 255.33M
Net Income (ttm) -138.47M
Shares Out 35.27M
EPS (ttm) -3.91
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 4,080
Average Volume 7,176
Open 31.94
Previous Close 30.25
Day's Range 29.51 - 31.94
52-Week Range 27.10 - 73.45
Beta 0.06
RSI 41.20
Earnings Date May 26, 2026

About Pharmaids Pharmaceuticals

Pharmaids Pharmaceuticals Limited, together with its subsidiaries, provides contract research and manufacturing services for pharma, biotech, agro, and chemical industries in India. The company offers pharma intermediates, such as Dichloro Benzoyl nitrile, hydrazine carboximidamide 2 methane, pyridine carbonitrile,pyridine carboxylic acid, 8-chloro-10, 11-dihydro-4-aza-5H-dibenzo cycloheptene-5-one, 8-chloro-6,11-dihydro-11 cyclohepta pyridine,2-amino-5-methylthiopene-3-carbonitrile, 5-methyl-2-amino]thiophene-3-carbonitrile, 4-amino-2-methyl-1... [Read more]

Industry Pharmaceutical Preparations
Founded 1989
Employees 28
Stock Exchange Bombay Stock Exchange
Ticker Symbol 524572
Full Company Profile

Financial Performance

In fiscal year 2025, Pharmaids Pharmaceuticals's revenue was 195.14 million, an increase of 27.54% compared to the previous year's 153.00 million. Losses were -107.77 million, 35.2% more than in 2024.

Financial Statements

News

There is no news available yet.